One-Year Extension Study of ACCORD COPD I: Safety and Efficacy of Two Doses of Twice-daily Aclidinium Bromide in Patients with COPD

By D'Urzo Anthony  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 4, 2013-08 ,pp. : 500-510

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study

By Beier Jutta  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 4, 2013-08 ,pp. : 511-522

Informa Healthcare

Access to resources Recommend Favorite

Sleep Disturbances and Refractory Gastroesophageal Reflux Disease Symptoms in Patients Receiving Once-Daily Proton Pump Inhibitors and Efficacy of Twice-Daily Rabeprazole Treatment

By  

Digestion, Vol. 88, Iss. 3, 2013-09 ,pp. : 145-152

Karger

Access to resources Recommend Favorite

Onset of Effect of Aclidinium, a Novel, Long-Acting Muscarinic Antagonist, in Patients with COPD

By Vestbo Jørgen   Vogelmeier Claus   Creemers Jacques   Falques Meritxell   Ribera Anna   Gil Esther Garcia  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 7, Iss. 5, 2010-09 ,pp. : 331-336

Informa Healthcare

Access to resources Recommend Favorite

The Safety and Efficacy of Arformoterol and Formoterol in COPD

By Hanania Nicola A.   Donohue James F.   Nelson Harold   Sciarappa Kenneth   Goodwin Elizabeth   Baumgartner R.A.   Hanrahan J. P.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 7, Iss. 1, 2011-02 ,pp. : 17-31

Informa Healthcare

Access to resources Recommend Favorite